Market Place
Sourcing Support
Zealand Pharma Launches 2026 LTI Program for Board and Management
19 Apr 2026 //
FIRSTWORD PHARMA
Zealand Pharma Names Eric Rojas Vp, Head Of Investor Relations
14 Apr 2026 //
GLOBENEWSWIRE
Zealand Pharma`s 2026 AGM Resolutions
26 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma Announces Financial Results For The Full Year 2025
19 Feb 2026 //
GLOBENEWSWIRE
Van Herk Investments B.V. Reveals Stake In Zealand Pharma
17 Oct 2025 //
GLOBENEWSWIRE
Zealand Pharma: Shares & Voting Rights As Of Sept 30, 2025
30 Sep 2025 //
GLOBENEWSWIRE
Zealand Pharma to Present at September 2025 Investor Conferences
28 Aug 2025 //
GLOBENEWSWIRE
Zealand Pharma`s Shares and Voting Rights as of June 30, 2025
30 Jun 2025 //
GLOBENEWSWIRE
Zealand Pharma Raises Share Capital from Employee Warrants
06 Jun 2025 //
GLOBENEWSWIRE
Zealand Pharma appoints Steven as Chief Development Officer
19 May 2025 //
GLOBENEWSWIRE
Zealand Pharma`s Q1 2025 Financial Results
08 May 2025 //
GLOBENEWSWIRE
Zealand Pharma conference call on May 8 at 2pm CET to present Q1
01 May 2025 //
GLOBENEWSWIRE
Zealand Pharma launches long-term incentive programs for 2025
19 Apr 2025 //
GLOBENEWSWIRE
Zealand Pharma shares transactions by company insiders
19 Apr 2025 //
GLOBENEWSWIRE
Resolutions from Zealand Pharma`s Annual General Meeting 2025
27 Mar 2025 //
GLOBENEWSWIRE
Zealand Pharma shareholder news: Van Herk Investments B.V.
25 Mar 2025 //
GLOBENEWSWIRE
Zealand Pharma completes enrollment in Phase 2b ZUPREME-1 trial
17 Mar 2025 //
GLOBENEWSWIRE
Roche pairs with Zealand Pharma on obesity drug candidate
12 Mar 2025 //
REUTERS
Zealand Pharma Announces Financial Results for the Full Year 2024
20 Feb 2025 //
GLOBENEWSWIRE
Zealand Pharma convenes its Annual General Meeting 2025
20 Feb 2025 //
GLOBENEWSWIRE
Zealand Pharma Announces Financial Results for Full Year 2024
20 Feb 2025 //
GLOBENEWSWIRE
Zealand Pharma to present at 43rd J.P. Morgan Conference on Jan
06 Jan 2025 //
GLOBENEWSWIRE
Zealand Pharma Announces Major Shareholder The Capital Group
25 Dec 2024 //
GLOBENEWSWIRE
Zealand Pharma Reports Share Transactions by Key Management
25 Dec 2024 //
GLOBENEWSWIRE
Zealand CEO: Novo`s CagriSema Data Supports Monotherapy Approach
20 Dec 2024 //
REUTERS
FDA declines to approve Zealand Pharma`s bowel disease drug
20 Dec 2024 //
REUTERS
Zealand Pharma Announces Financial Results for 9 Months of 2024
07 Nov 2024 //
GLOBENEWSWIRE
Zealand And Boehringer Win FDA Breakthrough For Fatty Liver
07 Oct 2024 //
REUTERS
Zealand Pharma Reports Total Shares & Voting Rights As Of Sept 30
30 Sep 2024 //
GLOBENEWSWIRE
Weight-loss market to see 16 new drugs by 2029, report estimates
11 Sep 2024 //
EXPRESSPHARMA
Zealand Pharma`s GLP-1/GLP-2 Agonist Achieves 8.3% Weight Loss
10 Sep 2024 //
FIERCE BIOTECH
Zealand Pharma Announces Positive Topline Results
09 Sep 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases Share Capital From Employee Warrants
22 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma seeks big pharma partners for obesity drug candidate
15 Aug 2024 //
REUTERS
Pharma’s Obsession With Obesity On Rise
01 Jul 2024 //
BIOSPECTRUM ASIA
Total number of shares and voting rights in Zealand Pharma at June 28, 2024
28 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Van Herk Investments
28 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma completes registration of capital increase
28 Jun 2024 //
GLOBENEWSWIRE
ICPO Theranostics Virtual Summit on Cancer Care, Nov 14-15, 2024
27 Jun 2024 //
GLOBENEWSWIRE
Zealand Launches Equity Offering Raising USD 900 Million / DKK 6.257 Billion
25 Jun 2024 //
GLOBENEWSWIRE
Zealand announces completion of an upsized equity offering of 8.35 million
25 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma Reports Positive Phase 1b Results For Petrelintide Trial
20 Jun 2024 //
GLOBENEWSWIRE
Zealand Increases its Share Capital of Exercise of Employee Warrants
13 Jun 2024 //
GLOBENEWSWIRE
Zealand Pharma At June 2024 Healthcare Investor Conferences
29 May 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Polar Capital
29 May 2024 //
GLOBENEWSWIRE
Zealand Pharma Announces Financial Results for the First Quarter of 2024
16 May 2024 //
GLOBENEWSWIRE
Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand
16 May 2024 //
ENDPTS
Zealand Pharma Q1 2024 Results Call On May 16
09 May 2024 //
GLOBENEWSWIRE
Zealand Launches 2024 LTI Programs For Board, Management, Employees
19 Apr 2024 //
GLOBENEWSWIRE
Zealand Pharma Director/Management Transactions Reported
19 Apr 2024 //
GLOBENEWSWIRE
Correction to Company announcement - No. 23 / 2024
19 Apr 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of EW
26 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand Pharma shares and/or related securities
26 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Van Herk Investments
21 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma`s Annual General Meeting 2024
20 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand shares &/or related securities by persons discharging
19 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma major shareholder announcement: Polar Capital
19 Mar 2024 //
GLOBENEWSWIRE
New Employee Elected Directors to the Board of Zealand Pharma A/S
13 Mar 2024 //
GLOBENEWSWIRE
Transactions in Zealand Pharma shares and/or related securities
08 Mar 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases its Share Capital
05 Mar 2024 //
GLOBENEWSWIRE
